Abstract
BackgroundTreatment with glucocorticoid (GC) is the preferred therapy for polymyalgia rheumatica (PMR), but half of the PMR patients experience a flare-up(s) of disease activity upon GC tapering or discontinuation. In...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have